Antiphospholipid antibody syndrome (APLS) is well known to cause thrombotic events and premature atherosclerosis leading to coronary artery occlusion. The association of non-thrombotic acute myocardial infarctions (AMI) with APLS is not as clearly delineated. The objective of this study was to determine the relative prevalence of myocardial infarction with non obstructive coronary arteries (MINOCA) compared to MI from vaso-occlusive disease amongst patients with known APLS at our institution. Out of 575 patients with positive antiphospholipid antibodies, cardiac catheterizations were performed in 40 patients presented with AMI and had cardiac catheterizations. MINOCA was found in 8 patients. We found that MINOCA is common in patients with A...
Background: Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) remains a challeng...
Myocardial infarction with non-obstructive coronary artery disease (MINOCA) accounts for approximate...
481-484Myocardial infarction (MI) is a multi-factorial disease which claims many young lives. There ...
Background Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are over...
Background: Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are over...
Background: Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are over...
Background: A significant proportion of patients presenting with acute myocardial infarction (MI) ha...
BACKGROUND: Antiphospholipid antibody syndrome (APS) is a disorder associated with both arterial and...
Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations that may preva...
Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations that may preva...
Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations that may preva...
Antiphospholipid syndrome (APS) is the most frequent cause of venous and arterial thrombotic events ...
Anti-phospholipid antibodies (aPL) are the serological biomarkers of anti-phospholipid syndrome (APS...
Antiphospholipid (aPL) antibodies entailing anticardiolipin (aCL) and anti-b2 glycoprotein I (anti-b...
>Myocardial infarction with no obstructive coronary atherosclerosis (MINOCA) is a syndrome with d...
Background: Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) remains a challeng...
Myocardial infarction with non-obstructive coronary artery disease (MINOCA) accounts for approximate...
481-484Myocardial infarction (MI) is a multi-factorial disease which claims many young lives. There ...
Background Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are over...
Background: Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are over...
Background: Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are over...
Background: A significant proportion of patients presenting with acute myocardial infarction (MI) ha...
BACKGROUND: Antiphospholipid antibody syndrome (APS) is a disorder associated with both arterial and...
Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations that may preva...
Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations that may preva...
Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations that may preva...
Antiphospholipid syndrome (APS) is the most frequent cause of venous and arterial thrombotic events ...
Anti-phospholipid antibodies (aPL) are the serological biomarkers of anti-phospholipid syndrome (APS...
Antiphospholipid (aPL) antibodies entailing anticardiolipin (aCL) and anti-b2 glycoprotein I (anti-b...
>Myocardial infarction with no obstructive coronary atherosclerosis (MINOCA) is a syndrome with d...
Background: Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) remains a challeng...
Myocardial infarction with non-obstructive coronary artery disease (MINOCA) accounts for approximate...
481-484Myocardial infarction (MI) is a multi-factorial disease which claims many young lives. There ...